Intrinsic Value of S&P & Nasdaq Contact Us

Paragon 28, Inc. FNA NYSE

NYSE • Healthcare • Medical - Devices • US • USD

SharesGrow Score
36/100
0/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$13.00
-0.7%

Stock Statistics — FNA

Paragon 28, Inc. (FNA) has a market capitalization of $1.1B and trades at $13.09. The 52-week range is 4.65-13.13.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -19.8, Earnings Per Share (EPS) of $-0.66, annual revenue of $256.18M.

The stock has a beta of 1.47, operates in the Healthcare sector.

Trading Data
Current Price$13.09
52-Week Range4.65-13.13
Volume16.57M
Avg Volume (30D)2.57M
Market Cap$1.1B
Beta (1Y)1.47
Company
IPO Date2021-10-15
Employees525
CEOAlbert DaCosta
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS69913P1057
CUSIP69913P105
Income (Latest Year)
Revenue$256.18M
Gross Profit$191.49M
EBITDA$-23.4M
Operating Income$-40.78M
Net Income$-54.64M
EPS$-0.66
EPS Diluted$-0.66
Shares Outstanding$83.31M
Balance Sheet (Latest Year)
Total Assets$290.72M
Current Assets$168.85M
Cash & ST Investments$34.58M
Total Liabilities$160.13M
Total Debt$640K
Net Debt$-33.94M
Total Equity$130.59M
Debt / Equity0.00
Valuation Ratios
P/E Ratio-19.8
P/S Ratio4.29
P/B Ratio8.41
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message